{"id":133839,"date":"2021-11-09T04:35:10","date_gmt":"2021-11-09T04:35:10","guid":{"rendered":"https:\/\/www.healthbenefitstimes.com\/glossary\/?p=133839"},"modified":"2023-08-25T10:50:46","modified_gmt":"2023-08-25T10:50:46","slug":"raloxifene","status":"publish","type":"post","link":"https:\/\/www.healthbenefitstimes.com\/glossary\/raloxifene\/","title":{"rendered":"Raloxifene"},"content":{"rendered":"<p>A drug used to prevent osteoporosis in postmenopausal women. Raloxifene (Evista) is a drug that works like an estrogen (female hormone] to stop bone loss in women after menopause. Raloxifene does not treat symptoms of menopause, such as hot flashes. The drug is also being studied for the prevention of breast cancer.<\/p>\n<hr \/>\n<p>A drug used to prevent and treat postmenopausal osteoporosis. Its action differs from hormone-replacement drugs in that it does not modify the symptoms of the menopause.<\/p>\n<hr \/>\n<p>A selective estrogen receptor modulator administered orally to treat and prevent osteoporosis in postmenopausal women. Its therapeutic class is bone resorption inhibitor.<\/p>\n<hr \/>\n<p>Raloxifene is a medication used to manage and prevent postmenopausal osteoporosis. However, it doesn&#8217;t offer relief for other menopausal issues like hot flashes. It&#8217;s important to note that this drug might be associated with a higher likelihood of developing deep vein thrombosis.<\/p>\n<hr \/>\n<p>&nbsp;<\/p>\n","protected":false},"excerpt":{"rendered":"<p>A drug used to prevent osteoporosis in postmenopausal women. Raloxifene (Evista) is a drug that works like an estrogen (female hormone] to stop bone loss in women after menopause. Raloxifene does not treat symptoms of menopause, such as hot flashes. The drug is also being studied for the prevention of breast cancer. A drug used [&hellip;]<\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[18],"tags":[],"class_list":["post-133839","post","type-post","status-publish","format-standard","hentry","category-r"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v21.1 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Raloxifene - Definition of Raloxifene<\/title>\n<meta name=\"description\" content=\"A drug used to prevent osteoporosis in postmenopausal women. Raloxifene (Evista) is a drug that works like an estrogen (female hormone] to stop bone loss in women after menopause. Raloxifene does not treat symptoms of menopause, such as hot flashes. The drug is also being studied for the prevention of breast cancer.A drug used to prevent and treat postmenopausal osteoporosis. Its action differs from hormone-replacement drugs in that it does not modify the symptoms of the menopause.A selective estrogen receptor modulator administered orally to treat and prevent osteoporosis in postmenopausal women. Its therapeutic class is bone resorption inhibitor.Raloxifene is a medication used to manage and prevent postmenopausal osteoporosis. However, it doesn&#039;t offer relief for other menopausal issues like hot flashes. It&#039;s important to note that this drug might be associated with a higher likelihood of developing deep vein thrombosis.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.healthbenefitstimes.com\/glossary\/raloxifene\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Raloxifene - Definition of Raloxifene\" \/>\n<meta property=\"og:description\" content=\"A drug used to prevent osteoporosis in postmenopausal women. Raloxifene (Evista) is a drug that works like an estrogen (female hormone] to stop bone loss in women after menopause. Raloxifene does not treat symptoms of menopause, such as hot flashes. The drug is also being studied for the prevention of breast cancer.A drug used to prevent and treat postmenopausal osteoporosis. Its action differs from hormone-replacement drugs in that it does not modify the symptoms of the menopause.A selective estrogen receptor modulator administered orally to treat and prevent osteoporosis in postmenopausal women. Its therapeutic class is bone resorption inhibitor.Raloxifene is a medication used to manage and prevent postmenopausal osteoporosis. However, it doesn&#039;t offer relief for other menopausal issues like hot flashes. It&#039;s important to note that this drug might be associated with a higher likelihood of developing deep vein thrombosis.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.healthbenefitstimes.com\/glossary\/raloxifene\/\" \/>\n<meta property=\"og:site_name\" content=\"Glossary\" \/>\n<meta property=\"article:published_time\" content=\"2021-11-09T04:35:10+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2023-08-25T10:50:46+00:00\" \/>\n<meta name=\"author\" content=\"Glossary\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Glossary\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/raloxifene\/\",\"url\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/raloxifene\/\",\"name\":\"Raloxifene - Definition of Raloxifene\",\"isPartOf\":{\"@id\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/#website\"},\"datePublished\":\"2021-11-09T04:35:10+00:00\",\"dateModified\":\"2023-08-25T10:50:46+00:00\",\"author\":{\"@id\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/#\/schema\/person\/ccfef987a4882e6356ae6d77d33e74c5\"},\"description\":\"A drug used to prevent osteoporosis in postmenopausal women. Raloxifene (Evista) is a drug that works like an estrogen (female hormone] to stop bone loss in women after menopause. Raloxifene does not treat symptoms of menopause, such as hot flashes. The drug is also being studied for the prevention of breast cancer.A drug used to prevent and treat postmenopausal osteoporosis. Its action differs from hormone-replacement drugs in that it does not modify the symptoms of the menopause.A selective estrogen receptor modulator administered orally to treat and prevent osteoporosis in postmenopausal women. Its therapeutic class is bone resorption inhibitor.Raloxifene is a medication used to manage and prevent postmenopausal osteoporosis. However, it doesn't offer relief for other menopausal issues like hot flashes. It's important to note that this drug might be associated with a higher likelihood of developing deep vein thrombosis.\",\"breadcrumb\":{\"@id\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/raloxifene\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.healthbenefitstimes.com\/glossary\/raloxifene\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/raloxifene\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Raloxifene\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/#website\",\"url\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/\",\"name\":\"Glossary\",\"description\":\"Difinitions\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/#\/schema\/person\/ccfef987a4882e6356ae6d77d33e74c5\",\"name\":\"Glossary\",\"url\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/author\/adminglossary\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Raloxifene - Definition of Raloxifene","description":"A drug used to prevent osteoporosis in postmenopausal women. Raloxifene (Evista) is a drug that works like an estrogen (female hormone] to stop bone loss in women after menopause. Raloxifene does not treat symptoms of menopause, such as hot flashes. The drug is also being studied for the prevention of breast cancer.A drug used to prevent and treat postmenopausal osteoporosis. Its action differs from hormone-replacement drugs in that it does not modify the symptoms of the menopause.A selective estrogen receptor modulator administered orally to treat and prevent osteoporosis in postmenopausal women. Its therapeutic class is bone resorption inhibitor.Raloxifene is a medication used to manage and prevent postmenopausal osteoporosis. However, it doesn't offer relief for other menopausal issues like hot flashes. It's important to note that this drug might be associated with a higher likelihood of developing deep vein thrombosis.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.healthbenefitstimes.com\/glossary\/raloxifene\/","og_locale":"en_US","og_type":"article","og_title":"Raloxifene - Definition of Raloxifene","og_description":"A drug used to prevent osteoporosis in postmenopausal women. Raloxifene (Evista) is a drug that works like an estrogen (female hormone] to stop bone loss in women after menopause. Raloxifene does not treat symptoms of menopause, such as hot flashes. The drug is also being studied for the prevention of breast cancer.A drug used to prevent and treat postmenopausal osteoporosis. Its action differs from hormone-replacement drugs in that it does not modify the symptoms of the menopause.A selective estrogen receptor modulator administered orally to treat and prevent osteoporosis in postmenopausal women. Its therapeutic class is bone resorption inhibitor.Raloxifene is a medication used to manage and prevent postmenopausal osteoporosis. However, it doesn't offer relief for other menopausal issues like hot flashes. It's important to note that this drug might be associated with a higher likelihood of developing deep vein thrombosis.","og_url":"https:\/\/www.healthbenefitstimes.com\/glossary\/raloxifene\/","og_site_name":"Glossary","article_published_time":"2021-11-09T04:35:10+00:00","article_modified_time":"2023-08-25T10:50:46+00:00","author":"Glossary","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Glossary","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.healthbenefitstimes.com\/glossary\/raloxifene\/","url":"https:\/\/www.healthbenefitstimes.com\/glossary\/raloxifene\/","name":"Raloxifene - Definition of Raloxifene","isPartOf":{"@id":"https:\/\/www.healthbenefitstimes.com\/glossary\/#website"},"datePublished":"2021-11-09T04:35:10+00:00","dateModified":"2023-08-25T10:50:46+00:00","author":{"@id":"https:\/\/www.healthbenefitstimes.com\/glossary\/#\/schema\/person\/ccfef987a4882e6356ae6d77d33e74c5"},"description":"A drug used to prevent osteoporosis in postmenopausal women. Raloxifene (Evista) is a drug that works like an estrogen (female hormone] to stop bone loss in women after menopause. Raloxifene does not treat symptoms of menopause, such as hot flashes. The drug is also being studied for the prevention of breast cancer.A drug used to prevent and treat postmenopausal osteoporosis. Its action differs from hormone-replacement drugs in that it does not modify the symptoms of the menopause.A selective estrogen receptor modulator administered orally to treat and prevent osteoporosis in postmenopausal women. Its therapeutic class is bone resorption inhibitor.Raloxifene is a medication used to manage and prevent postmenopausal osteoporosis. However, it doesn't offer relief for other menopausal issues like hot flashes. It's important to note that this drug might be associated with a higher likelihood of developing deep vein thrombosis.","breadcrumb":{"@id":"https:\/\/www.healthbenefitstimes.com\/glossary\/raloxifene\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.healthbenefitstimes.com\/glossary\/raloxifene\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.healthbenefitstimes.com\/glossary\/raloxifene\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.healthbenefitstimes.com\/glossary\/"},{"@type":"ListItem","position":2,"name":"Raloxifene"}]},{"@type":"WebSite","@id":"https:\/\/www.healthbenefitstimes.com\/glossary\/#website","url":"https:\/\/www.healthbenefitstimes.com\/glossary\/","name":"Glossary","description":"Difinitions","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.healthbenefitstimes.com\/glossary\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.healthbenefitstimes.com\/glossary\/#\/schema\/person\/ccfef987a4882e6356ae6d77d33e74c5","name":"Glossary","url":"https:\/\/www.healthbenefitstimes.com\/glossary\/author\/adminglossary\/"}]}},"_links":{"self":[{"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/posts\/133839","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/comments?post=133839"}],"version-history":[{"count":5,"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/posts\/133839\/revisions"}],"predecessor-version":[{"id":238268,"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/posts\/133839\/revisions\/238268"}],"wp:attachment":[{"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/media?parent=133839"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/categories?post=133839"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/tags?post=133839"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}